Name | Symbol | Markt | Aktientyp |
---|---|---|---|
Xenetic Biosciences Inc | XBIO | NASDAQ | Common Stock |
Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
---|---|---|---|---|
3,83 | 3,83 | 3,83 | 3,85 |
Aktuelle News
Datum | Zeit | Quelle | Überschrift |
---|---|---|---|
12.2.2024 | 15:15 | EDGAR2 | Form 8-K - Current report |
18.12.2023 | 23:18 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
18.12.2023 | 23:16 | EDGAR2 | Form 3 - Initial statement of beneficial ownership of.. |
08.12.2023 | 23:30 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
08.12.2023 | 23:30 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
08.12.2023 | 23:30 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
08.12.2023 | 23:30 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
08.12.2023 | 23:00 | EDGAR2 | Form 8-K - Current report |
13.11.2023 | 23:00 | EDGAR2 | Form DEF 14A - Other definitive proxy statements |
13.11.2023 | 14:30 | EDGAR2 | Form 8-K - Current report |
09.11.2023 | 23:00 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
18.9.2023 | 18:21 | EDGAR2 | Form SC 13D/A - General statement of acquisition of.. |
11.8.2023 | 14:05 | EDGAR2 | Form 8-K - Current report |
10.8.2023 | 22:30 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |